Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Active ingredient tirzepatide Form Single-dose vial, once weekly Maker Eli Lilly (Aspen in SA) Legal status Schedule 4 prescription required Approved for Dual-action (GIP/GLP-1) for type 2 diabetes and weight management
Metabolic & Adipose Tissue Research
That being said, different mechanisms may offer different side effect profiles, and its possible that future multi-agonists could yield improved tolerability profiles
By targeting both receptors, it regulates insulin secretion, slows down gastric emptying, and suppresses glucagon
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
